We subsequently focused on metabolic shift exhibited by AGC1-KD CRC cells, which mimicking the Oxa-resistance, at the baseline or under Oxaliplatin treatment stress, through monitoring the ratio of GSH to GSSG and the NADP+/NADPH ratio. The gene discussed is SLC25A12; the disease is colorectal carcinoma.